{"transactions":[{"id":3328730,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-31T20:27:25.000Z","date":"2019-12-27","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":250000,"derivative":{"exercise_price":0.4,"exercise_date":"2018-03-20","expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001510964-19-000082","document":"wf-form4_157782402829539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096419000082/wf-form4_157782402829539.xml","form_type":"4"}},{"id":3328729,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-12-31T20:27:25.000Z","date":"2019-12-27","kind":"exercise","acquired":true,"shares":250000,"price":0.4,"value":100000.0,"ownership":{"direct":true},"balance_after":1230000,"source":{"system":"sec-edgar","filing":"0001510964-19-000082","document":"wf-form4_157782402829539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096419000082/wf-form4_157782402829539.xml","form_type":"4"}},{"id":3942254,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-09T00:27:01.000Z","date":"2018-03-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The stock options are fully-vested on the Date of Grant."}],"balance_after":500000,"derivative":{"exercise_price":0.4,"exercise_date":"2018-03-20","expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001683168-18-001236","document":"mona3.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818001236/mona3.xml","form_type":"4"}},{"id":3980684,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-28T12:01:37.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On April 7, 2017, the Reporting Person was granted an option to purchase 1,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) when the Company has final meeting minutes from a pre-IND meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (ii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iii) when the Company commences its first human dosing under the IND (50% vesting of the shares subject to the option). On July 14, 2017, the first performance criterion was met resulting in vesting of the option as to 250,000 shares."}],"balance_after":250000,"derivative":{"exercise_price":0.365,"exercise_date":"2017-07-14","expiration_date":"2027-04-06","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-18-000771","document":"monaiii_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818000771/monaiii_f4.xml","form_type":"4"}},{"id":3980683,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-28T12:01:37.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On July 6, 2016, the Reporting Person was granted an option to purchase 4,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) the first time the Issuer completes development of a U.S. Food & Drug Administration (\"FDA\") current good manufacturing practice grade batch of successfully synthetically formulated Cannabidiol (\"CBD\") for use in drug development activities (25% vesting of the shares subject to the option); (ii) when the Company has final meeting minutes from a pre-investigational new drug application (\"IND\") meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (iii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iv) when the Company commences its first human dosing under the IND (25% vesting of the shares subject to the option)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On July 14, 2017, the second performance criterion was met resulting in vesting of the option as to 1,000,000 shares."}],"balance_after":1000000,"derivative":{"exercise_price":0.368,"exercise_date":"2017-07-14","expiration_date":"2026-07-05","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001683168-18-000771","document":"monaiii_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818000771/monaiii_f4.xml","form_type":"4"}},{"id":4367816,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-30T20:56:12.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested on the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":0.38,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-17-017743","document":"v462986_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000114420417017743/v462986_4.xml","form_type":"4"}},{"id":4578893,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":152793,"kind":"person","name":"Mona Michael III","position":1,"cik":"0001595068","reported_name":"Mona Michael III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-17T22:33:49.000Z","date":"2016-10-05","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See remarks below."}],"balance_after":1000000,"derivative":{"exercise_price":0.368,"exercise_date":"2016-10-05","expiration_date":"2026-07-05","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001683168-16-000332","document":"monaiii_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316816000332/monaiii_frm4.xml","form_type":"4"}}]}